Surgical Management of Disseminated Pulmonary Mucormycosis in the Immunocompromised

Surgical Management of Disseminated Pulmonary Mucormycosis in the Immunocompromised

Author Info

Corresponding Author
Justin D. Blasberg
Yale New Haven Hospital, Yale University, Connecticut, USA

A B S T R A C T

Background: Pulmonary mucormycosis is a rare and aggressive fungal infection that is known to predominantly affect immunocompromised hosts. Early surgical resection with prolonged antimycotic therapy is an established therapy for localized disease; however, the role of surgery in multifocal pulmonary disease is less clear. Case: We report successful treatment of medically refractory disseminated pulmonary mucormycosis with a salvage lobectomy and intrapleural antibiosis in a 58-year-old immunocompromised female. Conclusion: Surgery resection of necrotic foci in disseminated pulmonary mucormycosis is a viable surgical treatment option even if extensive resection is required. This treatment option should be considered early, given the high incidence of medically refractory disease.

Article Info

Article Type
Case Report
Publication history
Received: Wed 08, Apr 2020
Accepted: Thu 23, Apr 2020
Published: Thu 30, Apr 2020
Copyright
© 2023 Justin D. Blasberg. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.SCR.2020.04.09